Analgesics remained the largest category in OTC in Colombia in 2017. Similar to what is being seen globally, analgesics is a fairly mature category, with steady growth being driven by the proven efficacy of well-recognised brands and the ongoing efforts of manufacturers to introduce new formulations to better treat minor ailments which interfere with daily routines. In Colombia, migraine affects around 10% of the population, or five million people, with those aged 30-45 the most affected due to...

Euromonitor International’s Analgesics in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.